Selective antagonist for GluN2D subunit containing NMDA receptors. Binds competitively at the glutamate site.
Displays ~10- fold selectivity for GluN2D-containing receptors over GluN2B (NR2B) or GluN2A (NR2A) containing receptors (Ki values are 1.19, 7.99 and 11.53 at GluN1/GluN2D, GluN1/GluN2B and GluN1/GluN2A containing receptors respectively).
Inhibits synaptic NMDAR response.
Solubility & Handling
Storage instructions
-20°C
Solubility overview
Soluble in DMSO (100mM, gentle warming)
Important
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.
Different NMDA receptor subtypes mediate induction of long-term potentiation and two forms of short-term potentiation at CA1 synapses in rat hippocampus in vitro.
Volianskis et al (2013) J Physiol. 591(4) : 955-72
N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse.
Costa et al (2009) J Pharmacol Exp Ther 331(2) : 618-26